The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
Official Title: Personalized Circulating DNA Follow-up in Melanoma
Study ID: NCT04866680
Brief Summary: PERCIMEL is an open multicentric study. The purpose of this study is to assess the interest of molecular analysis on circulating tumor DNA in the follow-up of the disease.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
CHU Jean Minjoz, Besançon, , France
CGFL, Dijon, , France
Chu Dijon, Dijon, , France
Chru Lille, Lille, , France
Ghr Mulhouse Sud Alsace, Mulhouse, , France
Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy, , France
Chru Nancy, Vandœuvre-lès-Nancy, , France